Out of the 11 treatments for which recommendations were made, 10 received exclusively positive recommendations for use in TSC, of which vigabatrin, adrenocorticotropic hormone (ACTH) and everolimus had the highest number (≥4 each). Here, POMC is linked to tuberous sclerosis.